Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients: LIBERATE trial
D. Slebos (Groningen, Netherlands), S. Wright (Phoenix, United States of America), R. Sue (Phoenix, United States of America), M. Dransfield (Birmingham, United States of America), H. Rivas-Perez (Louisville, United States of America), T. Wiese (Louisville, United States of America), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), M. Wahidi (Durham, United States of America), H. De Oliviera (Porto Alegre, Brazil), B. Morrissey (Sacramento, United States of America), P. Cardoso (Sao Paulo, Brazil), S. Hays (San Francisco, United States of America), A. Majid (Boston, United States of America), N. Pastis (Charleston, United States of America), L. Kopas (Houston, United States of America), M. Vollenweider (Orlando, United States of America), P. Mcfadden (Los Angeles, United States of America), M. Machuzak (Cleveland, United States of America), D. Hsia (Torrance, United States of America), A. Sung (Palo Alto, United States of America), N. Jarad (Bristol, United Kingdom), M. Kornaszewska (Cardiff, United Kingdom), S. Hazelrigg (Springfield, United States of America), G. Krishna (Mountain View, United States of America), N. Ten Hacken (Groningen, Netherlands), N. Shargill (Redwood City, United States of America), G. Criner (Philadelphia, United States of America)
Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Slebos (Groningen, Netherlands), S. Wright (Phoenix, United States of America), R. Sue (Phoenix, United States of America), M. Dransfield (Birmingham, United States of America), H. Rivas-Perez (Louisville, United States of America), T. Wiese (Louisville, United States of America), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), M. Wahidi (Durham, United States of America), H. De Oliviera (Porto Alegre, Brazil), B. Morrissey (Sacramento, United States of America), P. Cardoso (Sao Paulo, Brazil), S. Hays (San Francisco, United States of America), A. Majid (Boston, United States of America), N. Pastis (Charleston, United States of America), L. Kopas (Houston, United States of America), M. Vollenweider (Orlando, United States of America), P. Mcfadden (Los Angeles, United States of America), M. Machuzak (Cleveland, United States of America), D. Hsia (Torrance, United States of America), A. Sung (Palo Alto, United States of America), N. Jarad (Bristol, United Kingdom), M. Kornaszewska (Cardiff, United Kingdom), S. Hazelrigg (Springfield, United States of America), G. Krishna (Mountain View, United States of America), N. Ten Hacken (Groningen, Netherlands), N. Shargill (Redwood City, United States of America), G. Criner (Philadelphia, United States of America). Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients: LIBERATE trial. 4932
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Impact of endobronchial valves on patient reported outcomes in severe emphysema Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019
Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves for the treatment of severe emphysema Source: Annual Congress 2008 - New trends in interventional pulmonology Year: 2008
Quality of forced spirometry in a worldwide multicenter clinical trial with moderate to severe COPD patients with emphysema Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results. Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017
STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016
International multicenter trial of bronchial valve treatment for severe emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 711s Year: 2007
Quality of diffusion measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema Source: International Congress 2016 – Advancements in bronchoscopy Year: 2016
Does physiotherapy reduce the incidence of postoperative pulmonary complications in patients following pulmonary resection via thoracotomy? A single blind randomised controlled trial Source: Annual Congress 2009 - Chest physiotherapy in critically ill patients Year: 2009
Chartis evaluation of collateral ventilation versus HRCT assessment, in predicting clinical outcomes following endobronchial valve therapy (EBV) in COPD patients Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012
Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT) Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016
Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial Source: Virtual Congress 2021 – New trends in non-invasive respiratory support Year: 2021
The effects of T-PEP on ventilation lung scan in patients with bronchiectasis: Protocol for a randomized controlled trial Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010
Factors associated with good response in a cohort of patients with severe emphysema and complete inter-lobar fissures undergoing endo-bronchial valve insertion Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Quality of Helium dilution lung volume measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
One year follow-up after endobronchial valve treatment in patients with emphysema without interlobar collateral ventilation Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016
Lung volume reduction coil treatment for patients with severe heterogeneous emphysema, a multicenter feasibility trial Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011